Condensed Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 1,570,693	$ 2,005,228
Prepaid expenses	139,015	262,516
Total Current Assets	1,709,708	2,267,744
Cash and marketable securities held in Trust Account	175,084,854	175,040,510
TOTAL ASSETS	176,794,562	177,308,254
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liability - accrued expenses	205,746	214,025
Deferred underwriting fee payable	6,125,000	6,125,000
Derivative warrant liabilities	10,054,568	15,198,000
Total Liabilities	16,385,314	21,537,025
Commitments and contingencies
Class A common stock subject to possible redemption, 17,500,000 shares issued and outstanding at redemption value of $10.00 per share as of September 30, 2021, and December 31, 2020	175,000,000	175,000,000
Stockholders’ Equity (Deficit)
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class A common stock, $0.0001 par value; 75,000,000 shares authorized at September 30, 2021, and December 31, 2020
Class B convertible common stock, $0.0001 par value; 10,000,000 shares authorized; 4,375,000 shares issued and outstanding as of September 30, 2021, and December 31, 2020	437	437
Additional paid-in capital	66	66
Accumulated deficit	(14,591,255)	(19,229,274)
Total Stockholders’ Equity (Deficit)	(14,590,752)	(19,228,771)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 176,794,562	$ 177,308,254